BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30692357)

  • 1. [The Implications of Conversion Surgery for Stage Ⅳ Gastric Cancer].
    Uraoka M; Higashida M; Ueno M; Mineta S; Okamoto Y; Kubota H; Watanabe Y; Okada T; Tsuruta A; Fujiwara Y; Ueno T
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1797-1799. PubMed ID: 30692357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of conversion gastrectomy for treatment of Stage IV advanced gastric cancer].
    Funaki H; Fujita J; Morioka E; Kaida D; Ohnishi T; Ohno Y; Tomita Y; Noguchi M; Fujita H; Kinami S; Nakano Y; Ueda N; Kosaka T
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1615-7. PubMed ID: 24393866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
    Zhu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion Surgery for Gastric Cancer with Peritoneal Metastasis Based on the Diagnosis of Second-Look Staging Laparoscopy.
    Nakamura M; Ojima T; Nakamori M; Katsuda M; Tsuji T; Hayata K; Kato T; Yamaue H
    J Gastrointest Surg; 2019 Sep; 23(9):1758-1766. PubMed ID: 30264385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
    Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
    Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Examination of outcomes after conversion surgery for Stage IVGastric cancer in our hospital].
    Hagino S; Kurata T; Makita N; Tsuneda A; Iwata K; Kiriyama M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2293-5. PubMed ID: 25731500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance and practice points of conversion therapy for gastric cancer with peritoneal metastasis].
    Zhu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1094-1098. PubMed ID: 29130218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of initial treatment for peritoneal lavage cytology-positive gastric cancer: outcomes according to treatment strategy.
    Yago A; Haruta S; Ueno M; Ogawa Y; Shimoyama H; Ohkura Y; Udagawa H
    World J Surg Oncol; 2022 Feb; 20(1):35. PubMed ID: 35168610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoresponse after non-curative gastrectomy for M1 gastric cancer.
    Shin HB; Lee SH; Son YG; Ryu SW; Sohn SS
    World J Surg Oncol; 2015 Jan; 13():13. PubMed ID: 25634223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.
    Kinoshita J; Fushida S; Tsukada T; Oyama K; Okamoto K; Makino I; Nakamura K; Miyashita T; Tajima H; Takamura H; Ninomiya I; Ohta T
    Eur J Surg Oncol; 2015 Oct; 41(10):1354-60. PubMed ID: 26028256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
    Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy.
    Beom SH; Choi YY; Baek SE; Li SX; Lim JS; Son T; Kim HI; Cheong JH; Hyung WJ; Choi SH; Jung M; Kim HS; Jeung HC; Chung HC; Rha SY; Noh SH
    BMC Cancer; 2018 Nov; 18(1):1116. PubMed ID: 30442107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
    Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
    Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer.
    Noh SH; Yoo CH; Chung HC; Roh JK; Shin DW; Min JS
    Oncology; 2001; 60(1):24-30. PubMed ID: 11150904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
    Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
    Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination.
    Okabe H; Ueda S; Obama K; Hosogi H; Sakai Y
    Ann Surg Oncol; 2009 Dec; 16(12):3227-36. PubMed ID: 19777180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognosis of Conversion Gastrectomy Cases for Stage IV Gastric Cancer].
    Ohnishi T; Kinami S; Fujii Y; Miura S; Fujita J; Kaida D; Tomita Y; Fujita H; Nakano Y; Ueda N; Kosaka T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1799-1801. PubMed ID: 29394780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features and prognosis analysis of 21 gastric cancer patients with pathological complete response after neoadjuvant chemotherapy].
    Peng L; Yang W; Zhang Z; Liu H; Hua Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1168-1173. PubMed ID: 29130233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion surgery for stage IV gastric cancer: a multicenter retrospective study.
    Kano Y; Ichikawa H; Hanyu T; Muneoka Y; Ishikawa T; Aizawa M; Matsuki A; Yabusaki H; Bamba T; Nakagawa S; Kobayashi K; Kuwabara S; Makino S; Kawachi Y; Naito T; Tani T; Hirukawa H; Tada T; Shimada Y; Sakata J; Wakai T
    BMC Surg; 2022 Dec; 22(1):428. PubMed ID: 36517780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
    Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S; Watanabe T
    Ann Surg Oncol; 2014 Feb; 21(2):539-46. PubMed ID: 23975319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.